Close
Back to mobile site

UBS Downgrades Biogen (BIIB) to Neutral

March 22, 2019 3:57 AM EDT
Get Alerts BIIB Hot Sheet
Price: $215.63 -0.33%

Rating Summary:
    29 Buy, 13 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 13 | Down: 11 | New: 11
Join SI Premium – FREE

UBS downgraded Biogen (NASDAQ: BIIB) from Buy to Neutral with a price target of $242.00 (from $395.00).

For an analyst ratings summary and ratings history on Biogen click here. For more ratings news on Biogen click here.

Shares of Biogen closed at $226.88 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst PT Change, Downgrades

Related Entities

UBS